Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Sarcoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Melanoma 1

Interventions

Cyclophosphamide 4Sirolimus 3pembrolizumab 2fludarabine 2etoposide phosphate 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Celecoxib 2Busulfan 2ripretinib 1repotrectinib 1pegylated granulocyte colony-stimulating factor 1interferon gamma-1b 1fludarabine phosphate 1bintrafusp alfa protein, human 1Vorinostat 1Ursodeoxycholic Acid 1Topotecan 1Thrombopoietin 1Thiotepa 1Therapeutics 1Tetrahydrouridine 1Stem Cell Transplantation 1Simvastatin 1Radiotherapy, Image-Guided 1Radiation 1Psychiatric Rehabilitation 1Plicamycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Tetrahydrouridine × Sarcoma × Clear all
NCT02839694 2018-07-05

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn
DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Neoplasms, Germ Cell and Embryonal, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡